Skip to main content
In stock | Hormonal Therapy

Relugolix

Oncology Type Solid Tumour (Prostate)
Drug Class / Mechanism GnRH Antagonist
No Image
Description

Relugolix is classified as a GnRH Antagonist, sourced for use within our Hormonal Therapy portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic Category Hormonal Therapy
Oncology Type Solid Tumour (Prostate)

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3